IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
Veronika Šandová, Gabriela Mladonická Pavlasová, Václav Šeda, Kateřina Amruz Černá, Sonali Sharma, Veronika Palušová, Yvona Brychtová, Šárka Pospı́šilová, Stacey M. Fernandes, Anna Panovská, Michael Doubek, Matthew S. Davids, Jennifer R. Brown, Jiřı́ Mayer, Marek Mráz
Abstract
Not available.
Topics & Concepts
IdelalisibChronic lymphocytic leukemiaCD20Cancer researchMedicineLeukemiaImmunologyIbrutinibAntibodyChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentImmunodeficiency and Autoimmune Disorders